Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer

The majority of breast cancers are oestrogen-receptor-positive (ER+) and are subject to endocrine therapy; however, an unpredictable subgroup of patients will develop resistance to endocrine therapy. The SLC7A5/SLC3A2 complex is a major route for the transport of large neutral essential amino acids...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfarsi, Lutfi H., El-Ansari, Rokaya, Craze, Madeleine L., Masisi, Brendah K., Mohammed, Omar J., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073058/
https://www.ncbi.nlm.nih.gov/pubmed/32093034
http://dx.doi.org/10.3390/ijms21041407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073058/
https://www.ncbi.nlm.nih.gov/pubmed/32093034
http://dx.doi.org/10.3390/ijms21041407

Ejemplares similares